MINERALYS THERAPEUTICS INC
MLYS
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company whose primary business is developing and commercializing pharmaceutical products. As part of its drug development process, the company conducts animal testing to support regulatory submissions for its product candidates, including its lead investigational drug for hypertension. This reliance on animal models is a standard, integral component of the company’s research and development pipeline.
The specific evidence detailing the scale, nature, or alternatives to this animal testing is not publicly available in the company’s SEC filings or immediate regulatory documents. The provided source materials reference general regulatory processes but do not contain the specific data on animal use required to assess the activity's materiality to the company's operations.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.